Search

Your search keyword '"Soto‐Ortolaza, Alexandra I."' showing total 207 results

Search Constraints

Start Over You searched for: Author "Soto‐Ortolaza, Alexandra I." Remove constraint Author: "Soto‐Ortolaza, Alexandra I."
207 results on '"Soto‐Ortolaza, Alexandra I."'

Search Results

1. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype

2. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies

3. LRRK2 variation and dementia with Lewy bodies

4. MAPT haplotype diversity in multiple system atrophy

6. TARDBP mutations in Parkinson's disease

8. Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease

9. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

13. Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinsonʼs disease (GEO-PD) consortium

14. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimerʼs diseases

17. Ataxin-2 repeat-length variation and neurodegeneration

18. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

19. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinsonʼs disease

21. Association of α-, β-, and γ-Synuclein With Diffuse Lewy Body Disease

22. The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

24. Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration

25. TREM2 p.R47H SUBSTITUTION IS NOT ASSOCIATED WITH DEMENTIA WITH LEWY BODIES

27. Genome-wide association study in essential tremor identifies three new loci

28. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies

29. Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease

30. Mitochondrial targeting sequence variants of theCHCHD2gene are a risk for Lewy body disorders

31. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies

32. Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus

33. VPS35 Mutations in Parkinson Disease

36. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

37. Analysis of COQ2gene in multiple system atrophy

38. VPS35 and DNAJC13 disease-causing variants in essential tremor

39. SLC1A2 rs3794087 does not associate with essential tremor

40. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

41. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

42. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

43. NOTCH3 Variants and Risk of Ischemic Stroke

44. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.

46. LRRK2 haplotype‐sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

48. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease

49. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.

50. LRRK2 exonic variants and risk of multiple system atrophy.

Catalog

Books, media, physical & digital resources